Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevanac vs Acular LS for Safety After Cataract Surgery
NCT00332774Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2006
- Primary completion
- Dec 2006
- Countries
- 1
01
Overview
A Phase 3 trial of nepafenac in cataract, sponsored by Alcon Inc.. Started Feb 2006; status: completed.
02
Drugs
nepafenac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00332774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332774.